| Market Cap | ₹4,295Cr |
| ROE | -19.58% |
| P/E Ratio(TTM) | -69.50 |
| EPS(TTM) | -18.63 |
| P/B Ratio | 6.33 |
| Dividend Yield | 0.07% |
| Industry P/E | 32.56 |
| Book Value | 204.50 |
| Debt to Equity | 0.57 |
| Face Value | 10 |
| Managing Director | Dr. Sujit Paul |
| Founded | 2000 |
| NSE Symbol | ZOTA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.07 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 35.82 | ||
| Wockhardt | NA (0.00%) | -451.61 | ||
| Cohance Lifesciences | NA (0.00%) | 50.91 |